Solarbetriebenes Krypto-Mining:
Die Strategie, die diese Aktie um 75 % steigen ließ!
Anzeige
SIRONA BIOCHEM WKN: A0RM6R ISIN: CA82967M1005 Forum: Aktien Thema: Hauptdiskussion
0,04575 EUR
-9,85 %-0,00500
19. Nov, 10:46:42 Uhr,
L&S Exchange
Kommentare 98.164
H
HAI90,
16.02.2024 17:07 Uhr
0
Oder Early 2024= Early 2025 und da ist dann Early 2026 auch nicht mehr weit ...
gr0unding,
16.02.2024 16:33 Uhr
0
Sirona Biochem Announces Plans For Commercial Launch of GlycoProteMim TFC-1326 in Early 2025
Sirona Biochem Corp. is pleased to announce the planned commercialization of GlycoProteMim™ through its subsidiary Sirona Laboratories. The company's Chief Scientific Officer, Dr. Geraldine Deliencourt-Godefroy, outlined the plan in a recent exclusive video interview with the Investing News Network.
In the interview, Dr. Deliencourt-Godefroy explained the company's plan to introduce a new line of anti-aging products containing GlycoProteMim™ under Sirona Laboratories. She explained that the products are scheduled to hit the North American, Canadian, and European markets in 2025.
Sirona Laboratories' product line is not just a collection of skincare essentials; but also a testament to our unwavering commitment to pushing the boundaries of anti-aging and cosmetic science.
The product line will include a 21-day ampoule anti-aging program pack, anti-aging facial creams, and an anti-wrinkle moisturizing hand cream, all of which will contain unique formulations with varying concentrations of GlycoProteMim™. Development and tests for the different product formulations are still ongoing.
Future Therapeutic Skincare Products
Anticellulite Treatment
Sirona Biochem is also advancing efforts to bring to market a distinct and innovative active compound, specially designed to effectively target and treat cellulite. A clinical trial is being scheduled. Once regulatory approval is obtained, the active will be used in a cream or serum that will become part of Sirona Laboratories' growing product line.
Given the absence of effective treatments in the market, our forthcoming potential solution for cellulite elimination presents a significant commercial opportunity.
r
rockharders,
16.02.2024 16:05 Uhr
0
schaut richtig madig aus, die verpackungen🤣
PeterG,
16.02.2024 15:56 Uhr
0
Ne, habe doch gesagt dass ich keinen Pfennig mehr in Sirona reinstecke. Wollte nur sagen dass jeder theoretisch seine Chance hatte... 😉
s
p
n
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | EVOTEC Hauptdiskussion | -5,96 % | |
2 | Dax Prognose | -1,05 % | |
3 | Super Micro Computer Hauptdiskussion | +29,37 % | |
4 | MicroStrategy | -0,04 % | |
5 | BAYER Hauptdiskussion | -0,26 % | |
6 | VW Hauptdiskussion | -1,98 % | |
7 | DAX Hauptdiskussion | -1,05 % | |
8 | NVIDIA Hauptdiskussion | +1,20 % | |
9 | Hexagon Purus | -8,92 % | |
10 | Nio für normale Kommunikation | +2,89 % | Alle Diskussionen |
Aktien
|
Thema | ||
---|---|---|---|
1 | EVOTEC Hauptdiskussion | -5,96 % | |
2 | Super Micro Computer Hauptdiskussion | +26,57 % | |
3 | MicroStrategy | -0,99 % | |
4 | BAYER Hauptdiskussion | -0,25 % | |
5 | VW Hauptdiskussion | -1,94 % | |
6 | Hexagon Purus | -8,92 % | |
7 | NVIDIA Hauptdiskussion | +1,19 % | |
8 | Nio für normale Kommunikation | +2,89 % | |
9 | Zeta Global Holdings | +5,39 % | |
10 | WAL-MART Hauptdiskussion | +1,52 % | Alle Diskussionen |